Case Reports
doi: 10.1080/10428190701671044.
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)
- PMID: 18067026
- DOI: 10.1080/10428190701671044
Item in Clipboard
Case Reports
Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)
Leuk Lymphoma.
2007 Dec.
No abstract available
Similar articles
-
Viral infection or reactivation in patients during treatment with dasatinib: a call for screening?Leuk Lymphoma. 2007 Dec;48(12):2308-9. doi: 10.1080/10428190701760086. Leuk Lymphoma. 2007. PMID: 18067004 No abstract available.
-
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005. Clin Ther. 2007. PMID: 18158072 Review.
-
Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.Int J Hematol. 2012 Sep;96(3):308-19. doi: 10.1007/s12185-012-1132-8. Epub 2012 Jul 6. Int J Hematol. 2012. PMID: 22767140
-
Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.Turk J Gastroenterol. 2014 Dec;25 Suppl 1:233. doi: 10.5152/tjg.2014.5281. Turk J Gastroenterol. 2014. PMID: 25910316 No abstract available.
-
Dasatinib: a guide to its use in chronic myeloid leukemia in the EU.BioDrugs. 2013 Jun;27(3):275-9. doi: 10.1007/s40259-013-0024-7. BioDrugs. 2013. PMID: 23549840 Review.
Cited by
-
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.Biomark Insights. 2016 Apr 21;10(Suppl 3):55-68. doi: 10.4137/BMI.S22430. eCollection 2015. Biomark Insights. 2016. PMID: 27127405 Free PMC article. Review.
-
Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.Blood. 2013 Jul 11;122(2):227-38. doi: 10.1182/blood-2012-11-465039. Epub 2013 May 29. Blood. 2013. PMID: 23719297 Free PMC article.
-
Dasatinib and FLAG-IDA Is an Effective Therapy for Initial Myeloid Blast Crisis but Involves a High Risk of Opportunistic Infections.Case Rep Hematol. 2020 Nov 11;2020:8867461. doi: 10.1155/2020/8867461. eCollection 2020. Case Rep Hematol. 2020. PMID: 33224541 Free PMC article.
-
Severe Refractory Anaemia and Fever of Unknow Origin: Human Parvovirus B19 Reactivation.Eur J Case Rep Intern Med. 2020 Jun 25;7(9):001596. doi: 10.12890/2020_001596. eCollection 2020. Eur J Case Rep Intern Med. 2020. PMID: 32908820 Free PMC article.
-
First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia.Blood Res. 2019 Jun;54(2):151-153. doi: 10.5045/br.2019.54.2.151. Epub 2019 Jun 25. Blood Res. 2019. PMID: 31309096 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
